Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$493,989
-$175,683 QoQ
Shares Held
3,910
-18.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,375
of 2,266 holders
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 14%
Shared 0%
None 86%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Inscription Capital, LLC holds $24,225,985 across 10 Drug Manufacturers - General names. GILD ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
29,836 | $7,577,448 | |
| 2 | ABBV |
AbbVie Inc.
|
20,373 | $5,126,661 | |
| 3 | LLY |
ELI LILLY & Co
|
4,139 | $4,964,441 | |
| 4 | MRK |
Merck & Co., Inc.
|
26,514 | $3,407,049 | |
| 5 | PFE |
Pfizer Inc
|
31,586 | $760,590 | |
| 6 | AMGN |
Amgen Inc
|
1,749 | $633,347 | |
| 7 | NVS |
Novartis AG
|
3,412 | $534,728 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
3,910 | $493,989 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $493,989 | 3,910 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $669,672 | 4,805 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $607,808 | 4,952 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $516,816 | 4,656 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $380,505 | 3,432 | Shares | Sole | 2025-08-12 | |
| 2022-06-30 | $271,778 | 4,397 | Shares | Sole | 2022-09-20 | |
| 2021-06-30 | $253,886 | 3,687 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||